About SpiroChem
SpiroChem is a Healthcare company based in Zurich (Switzerland) founded in 2011. It operates as a swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry. SpiroChem has completed 1 acquisition, including Cyclenium Pharma. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is SpiroChem AG. Its competitors include Sai Life Sciences, Acies Bio, Liverpool ChiroChem, IRBM and Personal Chemistry and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
SpiroChem was founded in 2011 in Zurich, Switzerland, as a fine chemicals company. Active pharmaceutical ingredients, intermediates, and custom synthesis services are supplied to the pharmaceutical and biotechnology sectors. Customized libraries of intermediates are developed based on client specifications. Operations focus on supporting research and development needs in these industries.
- Headquarters Zurich, Switzerland
- SectorsHealthcare
- Website spirochem.com
- Social LinkedIn X
- Legal Name Spirochem Ag
- Latest Funding Round$600.76K (USD), Grant
Apr 2020
- InvestorsEuropean Union
& 1 more
- Investments & Acquisitions
Funding Insights of SpiroChem
- Total Rounds 3
- Last Round Grant — $600,757
- First Round $11,324
(Jun 2011)
- Investors Count 2
All 3 funding rounds of SpiroChem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $600,757 | Grant | – | – | |
| Jul 2014 | – | Grant | – | – | – |
| Jun 2011 | $11,324 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in SpiroChem
SpiroChem has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | – | venturekick.ch | Schlieren, Switzerland | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for SpiroChem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SpiroChem
7 people are tracked at SpiroChem (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Anna Wozniak | Chief Financial Officer | Leadership |
Thomas Fessard | CEO | Leadership |
Gerhard Müller | Chief Scientific Officer | Leadership |
Florent Beaufils | Chief Operating Officer | Leadership |
Colin Bournez | Research Scientist - Computational Chemist | Team |
Sylvain Blanc | Research Chemist | Team |
Laurence Jung | Innovative Solutions Developer | Team |
Complete people profiles for SpiroChem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpiroChem
SpiroChem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cyclenium Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Canadian, preclinical-stage biopharma developing macrocycle drugs for oncology, infections, and pain | cyclenium.com | Montreal, Canada | 2013 | Jun 2023 | •••• |
Complete acquisition details for SpiroChem
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SpiroChem
4 dated milestones of SpiroChem across 12 years, from founding to its latest funding, stage changes and deals.
- Founded SpiroChem is founded.
- Funding First funding round of $11K.
- Funding Latest funding round, Grant, of $601K.
- Acquisition Acquires Cyclenium Pharma.
Competitors of SpiroChem
SpiroChem has 8 listed competitors in our database, 5 of them funded. They include Sai Life Sciences, Acies Bio, Liverpool ChiroChem, IRBM and Personal Chemistry, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| liverpoolchirochem.com | 2014 | Liverpool, United Kingdom | $11.07M | 14 | Small organic molecules are supplied for biotech and pharmaceutical R&D. | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| newiridium.com | 2016 | Boulder, United States | $2.65M | – | Phenoxazine and dihydrophenazine are manufactured by New Iridium. | |
| automeratx.com | 2022 | Singapore | $16M | – | Autophagy-driven degradation is pioneered through computational chemistry and AI. |
Detailed competitors of SpiroChem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SpiroChem
The website of SpiroChem (spirochem.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 44.3% vs previous month
Websites whose visitors overlap most with SpiroChem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
leatherchemists.org | leatherchemists.org | 100% | – | #11,900,110 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as SpiroChem (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spirochem
Complete news archive for SpiroChem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpiroChem
SpiroChem was founded in 2011.
SpiroChem is headquartered in Zurich, Switzerland.
SpiroChem was founded in 2011 in Zurich, Switzerland, as a fine chemicals company. Active pharmaceutical ingredients, intermediates, and custom synthesis services are supplied to the pharmaceutical and biotechnology sectors. Customized libraries of intermediates are developed based on client specifications. Operations focus on supporting research and development needs in these industries.
SpiroChem's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
SpiroChem has made 1 acquisition, including Cyclenium Pharma.
SpiroChem has 2 investors. Key investors include European Union, and Venture Kick.
SpiroChem operates through Spirochem Ag.